MXPA05003891A - Medicina que comprende una tiourea para utilizarse como un agente despigmentante o un agente antimutagenico y anticarcinogenico. - Google Patents

Medicina que comprende una tiourea para utilizarse como un agente despigmentante o un agente antimutagenico y anticarcinogenico.

Info

Publication number
MXPA05003891A
MXPA05003891A MXPA05003891A MXPA05003891A MXPA05003891A MX PA05003891 A MXPA05003891 A MX PA05003891A MX PA05003891 A MXPA05003891 A MX PA05003891A MX PA05003891 A MXPA05003891 A MX PA05003891A MX PA05003891 A MXPA05003891 A MX PA05003891A
Authority
MX
Mexico
Prior art keywords
medicine
agent
thiourea
mutagenic
depigmenting
Prior art date
Application number
MXPA05003891A
Other languages
English (en)
Inventor
Veronique Schwaab
Original Assignee
Lmd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lmd filed Critical Lmd
Publication of MXPA05003891A publication Critical patent/MXPA05003891A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Birds (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion se refiere a un medicamento o una composicion cosmetica que comprende al menos una tiourea de formula general I, o al menos uno de sus derivados de monoxido o dioxido de formulas generales (IIa), (IIb) y (III), o mezclas de los mismos; ventajosamente, este medicamento es utilizado para inhibir la tirosinasa, inhibir la sintesis de la melamina, aclarar o despigmentar la epidermis o eliminar las manchas ocasionadas por la edad y como agente anti-mutagenico y anti-carcinogenico.
MXPA05003891A 2002-10-11 2003-10-03 Medicina que comprende una tiourea para utilizarse como un agente despigmentante o un agente antimutagenico y anticarcinogenico. MXPA05003891A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0212697A FR2845599B1 (fr) 2002-10-11 2002-10-11 Medicament comprenant une thiouree pour son utilisation en tant que depigmentant
PCT/FR2003/002907 WO2004032912A1 (fr) 2002-10-11 2003-10-03 Medicament comprenant une thiouree pour son utilisation en tant que depigmentant ou agent antimutagene et anticarcinogene

Publications (1)

Publication Number Publication Date
MXPA05003891A true MXPA05003891A (es) 2005-08-03

Family

ID=32039668

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05003891A MXPA05003891A (es) 2002-10-11 2003-10-03 Medicina que comprende una tiourea para utilizarse como un agente despigmentante o un agente antimutagenico y anticarcinogenico.

Country Status (12)

Country Link
US (1) US20060135618A1 (es)
EP (1) EP1553933B1 (es)
JP (1) JP2006509733A (es)
KR (1) KR20050094806A (es)
AT (1) ATE367807T1 (es)
AU (1) AU2003286213A1 (es)
CA (1) CA2501742A1 (es)
DE (1) DE60315176D1 (es)
FR (1) FR2845599B1 (es)
MX (1) MXPA05003891A (es)
NO (1) NO20052176L (es)
WO (1) WO2004032912A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881654B1 (fr) * 2005-02-07 2009-05-29 Lmd Compositions medicinales contenant une alkylsulfone pour le traitement du cancer en association a des agents chimiotherapeutiques ou a des rayonnements ionisants ou non ionisants
WO2007039821A2 (en) * 2005-08-31 2007-04-12 Galderma Research & Development Novel inhibitors of tyrosinase, their method of preparation and their use in human medicine and in cosmetics
FR2890070A1 (fr) * 2005-08-31 2007-03-02 Galderma Res & Dev Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
WO2008015315A1 (fr) * 2006-08-03 2008-02-07 Lmd Compositions medicinales contenant une thiouree pour le traitement du cancer en association avec des agents chimiotherapeutiques ou des rayonnements ionisants ou non ionisants
CN102695503A (zh) * 2009-06-09 2012-09-26 马迪医学有限公司 卤代脂族羧酸、其寡聚物和/或聚合物和它们使外部和内部瘤失活的用途
BE1019432A3 (fr) * 2010-07-23 2012-07-03 Auriga Internat Utilisation d'isothiocyanates et derives pour le traitement et/ou la prevention des lucites.
BE1019431A3 (fr) * 2010-07-23 2012-07-03 Auriga Internat Procede de synthese d'isothiocyanates et leurs derives et utilisations de ceux-ci.
PL2854861T3 (pl) 2012-06-01 2018-02-28 Pharmagra Labs Inc Sposób syntetyzowania sulforafanu
TWI508950B (zh) * 2014-08-29 2015-11-21 Univ Hungkuang 3-methyl-2-sulfanyl-2,3-dihydro-1H-imidazole-1-carboxylic acid Tertiary butyl ester and its preparation method and use
WO2018046243A1 (en) 2016-09-06 2018-03-15 Unilever N.V. Compounds for reducing cellular melanin content
KR102201385B1 (ko) * 2018-10-11 2021-01-11 주식회사 그라젬 피부 미백용 조성물 및 이를 이용한 미백용 화장품

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411986A (en) * 1993-03-12 1995-05-02 The Johns Hopkins University Chemoprotective isothiocyanates
EP1857109B1 (en) * 2000-02-29 2010-09-22 MediQuest Therapeutics, Inc. Inhibitors of melanocyte tyrosinase as topical skin lighteners
FR2820036B1 (fr) * 2001-01-26 2005-12-09 L M D Utilisation d'un isothiocyanate, d'un thiocyanate ou de leur melange en tant que depigmentant

Also Published As

Publication number Publication date
AU2003286213A1 (en) 2004-05-04
NO20052176L (no) 2005-05-03
ATE367807T1 (de) 2007-08-15
JP2006509733A (ja) 2006-03-23
DE60315176D1 (de) 2007-09-06
KR20050094806A (ko) 2005-09-28
EP1553933B1 (fr) 2007-07-25
CA2501742A1 (fr) 2004-04-22
WO2004032912A1 (fr) 2004-04-22
FR2845599B1 (fr) 2005-01-07
FR2845599A1 (fr) 2004-04-16
US20060135618A1 (en) 2006-06-22
EP1553933A1 (fr) 2005-07-20

Similar Documents

Publication Publication Date Title
WO2004105736A8 (de) Verwendung von diphenylmethan-derivaten als tyrosinase-inhibitoren
WO2001085106A3 (de) Kosmetisches mittel enthaltend 2-furanonderivate
WO2007110415A3 (en) Use of diacetyl trimers and cosmetic or therapeutic formulations containing these compounds
AR029733A1 (es) Composicion principalmente cosmetica o farmaceutica que se presenta en forma solida
MXPA05003891A (es) Medicina que comprende una tiourea para utilizarse como un agente despigmentante o un agente antimutagenico y anticarcinogenico.
PH12012501351A1 (en) Synthesis of eporthilones, intermediates thereto, analogues and uses thereof
AU2003263878A1 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
ATE343366T1 (de) Kapseln zum einbau in waschmittel- oder körperpflegezusammensetzungen
TW200637588A (en) Whitening agent
MXPA03002911A (es) Compuestos quimicos.
ATE322878T1 (de) Biotin enthaltende galenische formulierung
DK0823903T3 (da) Heterocykliske biarylforbindelser, farmaceutiske præparater og kosmetiske sammensætninger, der indeholder dem, og anvendelser
WO2003026605A3 (fr) Composition cosmetique pour le soin de la peau et des cheveux de l&#39;homme
DE60327936D1 (de) Modulatoren von ship-1
ID29221A (id) Komposisi kosmetik perawatan kulit yang mengandung 4-kromanon
GEP20043202B (en) Resorcinol Derivatives
HK1087010A1 (en) Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions
AU2003273843A8 (en) Use of skin-protecting substances
ATE280570T1 (de) Coffein enthaltende zusammensetzung als hauptflegemittel
DE602004002366D1 (de) Lipid A und Lipid A enthaltende topische, insbesondere kosmetische, Zusammensetzung
DE502004002112D1 (de) Kosmetikum zur depigmentierung
WO2005037239A3 (de) Verwendung einer verbindung aus der gruppe der heterodiazole oder eines salzes der verbindung, die verbindung oder das salz enthaltende kosmetische oder therapeutische formulierung, die verbindung oder das salz als therapeutisches mittel sowie das salz selbst
WO2002083627A3 (de) Liganden des integrins alpha-v-beta-6
HUP0302880A2 (hu) Egy ciklusos depszipeptid javított aktivitással rendelkező kristályos formáját tartalmazó gyógyászati készítmények
MXPA05012500A (es) Agentes depigmentantes.